Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients

Journal of Infection

Volumn 68, Issue 2, 2014, Pages 176-184

  Guzmán Fulgencio, María ^a   García Álvarez, Mónica ^a   Berenguer, Juan ^b,c   Jiménez Sousa, Ma Ángeles ^a   Cosín, Jaime ^b   Pineda Tenor, Daniel ^a   Carrero, Ana ^b,c   Aldámiz, Teresa ^b,c   Álvarez, Emilio ^b   López, Juan Carlos ^b   Resino, Salvador ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

AIDS; Antiviral therapy; Chronic hepatitis C; Hepatic biopsy; Liver fibrosis; Vitamin D

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIFEDIOL; GAMMA GLUTAMYLTRANSFERASE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NECROINFLAMMATORY ACTIVITY GRADE; NUTRITIONAL STATUS; PATIENT CODING; RETROSPECTIVE STUDY; SEASONAL VARIATION; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT RESPONSE; VIRAL PHENOMENA AND FUNCTIONS; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AIDS; ANTIVIRAL THERAPY; CHRONIC HEPATITIS C; HEPATIC BIOPSY; LIVER FIBROSIS; VITAMIN D;

ADULT; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84892434390     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.10.011     Document Type: Article

References (42)

1. Rosenthal E., Salmon-Céron D., Lewden C., Bouteloup V., Pialoux G., Bonnet F., et al. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19). HIV Med 2009, 10(5):282-289.
2. Lopez-Dieguez M., Montes M.L., Pascual-Pareja J.F., Quereda C., Von Wichmann M.A., Berenguer J., et al. The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients. AIDS 2011, 25(7):899-904. [Epub 2011/02/19].
3. Macias J., Berenguer J., Japon M.A., Giron J.A., Rivero A., Lopez-Cortes L.F., et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 2009, 50(4):1056-1063. [Epub 2009/08/12].
4. Naggie S., Sulkowski M.S. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology 2012, 142(6):1324-1334.e3. [Epub 2012/04/28].
5. Griffin A.T., Arnold F.W. Review of metabolic, immunologic, and virologic consequences of suboptimal vitamin D levels in HIV infection. AIDS Patient Care STDS 2012, 26(9):516-525. [Epub 2012/08/07].
6. Gutierrez J.A., Parikh N., Branch A.D. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis 2011, 31(4):387-398. [Epub 2011/12/23].
7. (SACN) SACoN Update on vitamin D: position statement by the Scientific Advisory Committee on Nutrition 2007.
8. Barchetta I., Carotti S., Labbadia G., Gentilucci U.V., Muda A.O., Angelico F., et al. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 2012, 56(6):2180-2187. [Epub 2012/07/04].
9. von Essen M.R., Kongsbak M., Schjerling P., Olgaard K., Odum N., Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010, 11(4):344-349. [Epub 2010/03/09].
10. Abramovitch S., Dahan-Bachar L., Sharvit E., Weisman Y., Ben Tov A., Brazowski E., et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011, 60(12):1728-1737. [Epub 2011/08/06].
11. Song B.J., Rockey D.C. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver Int 2013, 33(5):653-655. [Epub 2013/04/09].
12. Terrier B., Carrat F., Geri G., Pol S., Piroth L., Halfon P., et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011, 55(4):756-761.
13. Dao C.N., Patel P., Overton E.T., Rhame F., Pals S.L., Johnson C., et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011, 52(3):396-405.
14. Mehta S., Giovannucci E., Mugusi F.M., Spiegelman D., Aboud S., Hertzmark E., et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010, 5(1):e8770.
15. Van Den Bout-Van Den Beukel C.J., Fievez L., Michels M., Sweep F.C., Hermus A.R., Bosch M.E., et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008, 24(11):1375-1382. [Epub 2008/10/22].
16. El-Maouche D., Mehta S.H., Sutcliffe C.G., Higgins Y., Torbenson M.S., Moore R.D., et al. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antivir Ther 2013, 18(2):237-242. [Epub 2012/08/23].
17. Welz T., Childs K., Ibrahim F., Poulton M., Taylor C.B., Moniz C.F., et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010, 24(12):1923-1928. [Epub 2010/07/01].
18. Mueller N.J., Fux C.A., Ledergerber B., Elzi L., Schmid P., Dang T., et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010, 24(8):1127-1134. [Epub 2010/02/20].
19. Baur K., Mertens J.C., Schmitt J., Iwata R., Stieger B., Eloranta J.J., et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012, 32(4):635-643. [Epub 2011/12/14].
20. Petta S., Cammà C., Scazzone C., Tripodo C., Di Marco V., Bono A., et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010, 51(4):1158-1167.
21. Lange C.M., Bojunga J., Ramos-Lopez E., von Wagner M., Hassler A., Vermehren J., et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011, 54(5):887-893.
22. Bitetto D., Fattovich G., Fabris C., Ceriani E., Falleti E., Fornasiere E., et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011, 53(4):1118-1126. [Epub 2011/04/12].
23. Milazzo L., Mazzali C., Bestetti G., Longhi E., Foschi A., Viola A., et al. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res 2011, 9(3):186-193.
24. Mandorfer M., Reiberger T., Payer B.A., Ferlitsch A., Breitenecker F., Aichelburg M.C., et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN+RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013, 27(2):227-232. 10.1097/QAD.0b013e32835aa161.
25. Falleti E., Bitetto D., Fabris C., Fattovich G., Cussigh A., Cmet S., et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012, 56(5):1641-1650. [Epub 2012/05/23].
26. Abu-Mouch S., Fireman Z., Jarchovsky J., Zeina A.R., Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J Gastroenterol 2011, 17(47):5184-5190. [Epub 2012/01/05].
27. Kitson M.T., Dore G.J., George J., Button P., McCaughan G.W., Crawford D.H., et al. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol 2013, 58(3):467-472. [Epub 2012/11/28].
28. Corey K.E., Zheng H., Mendez-Navarro J., Delgado-Borrego A., Dienstag J.L., Chung R.T. Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One 2012, 7(2):e27144. [Epub 2012/02/24].
29. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. [Epub 1985/07/01].
30. Thein H.H., Yi Q., Dore G.J., Krahn M.D. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008, 22(15):1979-1991. [Epub 2008/09/12].
31. Machado M.V., Oliveira A.G., Cortez-Pinto H. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors. Hepatology 2010, 52(1):71-78. [Epub 2010/06/26].
32. Eslam M., Lopez-Cortes L.F., Romero-Gomez M. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients. Curr Opin HIV AIDS 2011, 6(6):553-558. [Epub 2011/09/22].
33. Jacobs W.H.G.S., Balint J.A., Boyce H.W., Browning T.H., Cooper J.N., Earnest D.L., et al. Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 1989, 34(3):322-323.
34. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996, 24(2):289-293.
35. Soriano V., Puoti M., Sulkowski M., Cargnel A., Benhamou Y., Peters M., et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007, 21(9):1073-1089. [Epub 2007/05/16].
36. Arteh J., Narra S., Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010, 55(9):2624-2628.
37. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
38. Petta S., Craxi A. How to optimize HCV therapy in genotype 1 patients: predictors of response. Liver Int 2013, 33(Suppl. 1):23-29. [Epub 2013/01/11].
39. Branch A.D., Kang M., Hollabaugh K., Wyatt C.M., Chung R.T., Glesby M.J. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. Am J Clin Nutr 2013, 98(2):423-429. [Epub 2013/06/07].
40. Rahman A.H., Branch A.D. Vitamin D for your patients with chronic hepatitis C?. J Hepatol 2013, 58(1):184-189. [Epub 2012/08/09].
41. Bitetto D., Fabris C., Fornasiere E., Pipan C., Fumolo E., Cussigh A., et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011, 24(1):43-50. [Epub 2010/07/24].
42. Nimer A., Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients. World J Gastroenterol 2012, 18(8):800-805. [Epub 2012/03/01].